APA
Osinusi A., Meissner E. G., Lee Y., Bon D., Heytens L., Nelson A., Sneller M., Kohli A., Barrett L., Proschan M., Herrmann E., Shivakumar B., Gu W., Kwan R., Teferi G., Talwani R., Silk R., Kotb C., Wroblewski S., Fishbein D., Dewar R., Highbarger H., Zhang X., Kleiner D., Wood B. J., Chavez J., Symonds W. T., Subramanian M., McHutchison J., Polis M. A., Fauci A. S., Masur H. & Kottilil S. (20130902). Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. : JAMA.
Chicago
Osinusi Anuoluwapo, Meissner Eric G, Lee Yu-Jin, Bon Dimitra, Heytens Laura, Nelson Amy, Sneller Michael, Kohli Anita, Barrett Lisa, Proschan Michael, Herrmann Eva, Shivakumar Bhavana, Gu Wenjuan, Kwan Richard, Teferi Geb, Talwani Rohit, Silk Rachel, Kotb Colleen, Wroblewski Susan, Fishbein Dawn, Dewar Robin, Highbarger Helene, Zhang Xiao, Kleiner David, Wood Brad J, Chavez Jose, Symonds William T, Subramanian Mani, McHutchison John, Polis Michael A, Fauci Anthony S, Masur Henry and Kottilil Shyamasundaran. 20130902. Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. : JAMA.
Harvard
Osinusi A., Meissner E. G., Lee Y., Bon D., Heytens L., Nelson A., Sneller M., Kohli A., Barrett L., Proschan M., Herrmann E., Shivakumar B., Gu W., Kwan R., Teferi G., Talwani R., Silk R., Kotb C., Wroblewski S., Fishbein D., Dewar R., Highbarger H., Zhang X., Kleiner D., Wood B. J., Chavez J., Symonds W. T., Subramanian M., McHutchison J., Polis M. A., Fauci A. S., Masur H. and Kottilil S. (20130902). Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. : JAMA.
MLA
Osinusi Anuoluwapo, Meissner Eric G, Lee Yu-Jin, Bon Dimitra, Heytens Laura, Nelson Amy, Sneller Michael, Kohli Anita, Barrett Lisa, Proschan Michael, Herrmann Eva, Shivakumar Bhavana, Gu Wenjuan, Kwan Richard, Teferi Geb, Talwani Rohit, Silk Rachel, Kotb Colleen, Wroblewski Susan, Fishbein Dawn, Dewar Robin, Highbarger Helene, Zhang Xiao, Kleiner David, Wood Brad J, Chavez Jose, Symonds William T, Subramanian Mani, McHutchison John, Polis Michael A, Fauci Anthony S, Masur Henry and Kottilil Shyamasundaran. Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. : JAMA. 20130902.